Genflow appoints Gad Berdugo as independent non-executive chairman

• Genflow named Gad Berdugo as independent non-executive chairman in January 2026.
• Berdugo brings more than 30 years of biotech leadership, including former chief business officer roles at Editas Medicine and Nutcracker Therapeutics.
• Director Tamara Joseph remains on the board.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genflow Biosciences plc published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202607130200ACCESSWRNAPR_____1190047) on July 13, 2026, and is solely responsible for the information contained therein.